These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 3293499
1. The advantages of immunosuppressive therapy in renal disease. Zucchelli P. Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499 [Abstract] [Full Text] [Related]
2. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B. N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605 [Abstract] [Full Text] [Related]
3. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. Ponticelli C, Zucchelli P, Passerini P, Cesana B. N Engl J Med; 1992 Aug 27; 327(9):599-603. PubMed ID: 1640953 [Abstract] [Full Text] [Related]
4. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T. N Engl J Med; 1984 Apr 12; 310(15):946-50. PubMed ID: 6366560 [Abstract] [Full Text] [Related]
5. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy. Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B. Kidney Blood Press Res; 2009 Apr 12; 32(4):263-7. PubMed ID: 19776643 [Abstract] [Full Text] [Related]
6. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy. Ardiles LG, Mezzano SA. Clin Nephrol; 1996 Jun 12; 45(6):423. PubMed ID: 8793243 [No Abstract] [Full Text] [Related]
7. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy. Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F. Proc Eur Dial Transplant Assoc; 1983 Jun 12; 19():717-23. PubMed ID: 6348763 [Abstract] [Full Text] [Related]
8. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R. J Am Soc Nephrol; 1998 Mar 12; 9(3):444-50. PubMed ID: 9513907 [Abstract] [Full Text] [Related]
9. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome. Polenakovic M, Grcevska L, Dzikova S. Prilozi; 2006 Dec 12; 27(2):5-12. PubMed ID: 17211287 [Abstract] [Full Text] [Related]
10. Long-term treatment and prognosis of rapidly progressive glomerulonephritis. Keller F, Oehlenberg B, Kunzendorf U, Schwarz A, Offermann G. Clin Nephrol; 1989 Apr 12; 31(4):190-7. PubMed ID: 2714023 [Abstract] [Full Text] [Related]
11. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients. Schena FP. J Nephrol; 1999 Apr 12; 12 Suppl 2():S125-30. PubMed ID: 10688412 [Abstract] [Full Text] [Related]
12. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity. du Buf-Vereijken PW, Wetzels JF. Nephrol Dial Transplant; 2004 Aug 12; 19(8):2036-43. PubMed ID: 15187191 [Abstract] [Full Text] [Related]
13. Evaluation of efficacy of methylprednisolone, prednisolone and chlorambucil in idiopathic glomerulonephritis. Nand N, Das R, Jaswal TS. J Indian Med Assoc; 1997 Jun 12; 95(6):163-5, 174. PubMed ID: 9420390 [Abstract] [Full Text] [Related]
14. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study. Glöckner WM, Sieberth HG, Wichmann HE, Backes E, Bambauer R, Boesken WH, Bohle A, Daul A, Graben N, Keller F. Clin Nephrol; 1988 Jan 12; 29(1):1-8. PubMed ID: 3289804 [Abstract] [Full Text] [Related]
15. [Immunosuppressive therapy of glomerulonephritis--controlled studies]. Ferrari P, Frey FJ. Ther Umsch; 1993 Feb 12; 50(2):119-29. PubMed ID: 8456416 [Abstract] [Full Text] [Related]
16. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome]. Duman VL, Shkerina LI, Shilov EM. Klin Med (Mosk); 2005 Feb 12; 83(10):48-50. PubMed ID: 16320847 [Abstract] [Full Text] [Related]
17. Clinical and morphologic evolution of idiopathic membranous nephropathy. Zucchelli P, Cagnoli L, Pasquali S, Casanova S, Donini U. Clin Nephrol; 1986 Jun 12; 25(6):282-8. PubMed ID: 3524923 [Abstract] [Full Text] [Related]
18. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C. Kidney Int; 1995 Nov 12; 48(5):1600-4. PubMed ID: 8544420 [Abstract] [Full Text] [Related]